[ Price : $8.95]
FDA orders a boxed warning on labeling for two prescription bowel cleansing products due to risk of a type of kidney injury.[ Price : $8.95]
Federal Register Notice: FDA releases a revised draft guidance on the labeling of nonprescription human drugs products marketed wi...[ Price : $8.95]
Federal Register Final rule: FDA approves an Ivy Labs sANADA for increased levels of monensin in Type C medicated feeds for heifer...[ Price : $8.95]
Rep. Barton asks why FDA waited six months to seize contaminated heparin after twice warning the manufacturer that its recall effo...[ Price : $8.95]
PhRMA revises its DTC Guiding Principles and will release names of companies promising to comply.[ Price : $8.95]
An FDA advisory committee recommends approval of Genzymes Synvisc-One, intended for use in relieving pain associated with osteoart...[ Price : $8.95]
FDAs Cardiovascular and Renal Drugs Advisory Committee says Acuspheres Imagify doesnt offer enough benefit to overcome its risks....[ Price : $8.95]
FDA and HHS issue guidances on use of data when a subject is no longer participating in a clinical trial.